Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
An open label study to investigate the safety and feasibility of delivering 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy to patients with posttraumatic stress disorder
This study is no longer accepting new participants.
In Australia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Investigate the Safety, Tolerability, and Pharmacodynamics of JNJ-54175446 in Subjects With Major Depressive Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including BerlinA First in Human Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Oral Doses of KYN-5356 in Adult, Healthy Subjects
This study has finished and is no longer accepting participants.
In Glendale
Prevalence of ADHD and Health Outcomes in Adult Outpatients With Psychiatric Disorders: a Multi-country, Two-part, Observational Study
This study has finished and is no longer accepting participants.
Multiple locations, including BurnabyProspective, Observational Survey Study Assessing Effectiveness of Zuranolone in Improving PPD Symptoms in the Real-world Setting
This study has finished and is no longer accepting participants.
In WoonsocketRECONNECT-S ALPHA: A Non-interventional Study to Observe Real-life Allocation of Antipsychotics in the Acute Inpatient Management of Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including ChitaPhase 1, Double Blind, Sponsor Open, Randomized, Placebo Controlled, Dose Escalation, Parallel Group Study To Investigate The Safety, Tolerability And Pharmacokinetics Of Repeat Doses Of PF-06412562 In Healthy Subjects
This study has finished and is no longer accepting participants.
In New HavenKorea Post-Marketing Surveillance of Invega Sustenna
This study has finished and is no longer accepting participants.
In KyungKiResearchers compared BI 1358894 and placebo, tracking side effects to assess safety in people with borderline personality difficulties.
This study has finished and is no longer accepting participants.
Multiple locations, including AnaheimResearchers compared 5 mg BI 1569912, 10 mg BI 1569912, 20 mg of BI 1569912 and placebo to find out how the approaches affected depression symptoms in people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including BellflowerA Phase II, 6-week, Multicenter, Randomized, Double Blind (Patient and Investigator) or Masked, Placebo Controlled, Dose-finding Trial to Evaluate the Efficacy, Tolerability, and Safety of Different Doses of Oral BI 1569912 as Adjunctive Therapy in MD
This study has finished and is no longer accepting participants.
Multiple locations, including TucsonDouble-blind, Randomized, Parallel Group, Placebo Controlled Clinical Trial to Evaluate the Effects of Atomoxetine on Impulsivity in Behavioral Laboratory Tasks in Adult ADHD Patients
This study has finished and is no longer accepting participants.
Multiple locations, including AachenWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.